CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Vitreo-Retinal Associates, Michigan

Academic/Hospital

Also known as: Louis C. Glazer, MD | Vitreo Retinal Associates | Vitreo-Retinal Associates | Vitreo-Retinal Associates, Michigan | Vitreo Retinal Associates, PA | Vitreo-Retinal Associates, PC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Feb 28, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 5 trials)

Phase 4 (1 own, 0 via acquisition)

ranibizumab

Phase 3 (1 own, 0 via acquisition)

acetylcysteine

Phase 2 (1 own, 0 via acquisition)

ico-007

Other trials (1 own, 0 via acquisition)

bevacizumab

Indications

Studied for

Recent trials (9)

NCT05537220CollaboratorPhase 3Feb 28, 2023
NCT03097068Lead sponsorPhase 4Apr 19, 2017
NCT03097068Sponsor investigatorPhase 4Apr 19, 2017
NCT01565148Overall official - principal investigatorPhase 2Feb 1, 2012
NCT01472510Overall official - principal investigatorPhase 2Dec 1, 2011
NCT01472510Study directorPhase 2Dec 1, 2011
NCT01472510Lead sponsorPhase 2Dec 1, 2011
NCT01473251Overall official - principal investigatorN/ANov 1, 2011
NCT01473251Lead sponsorN/ANov 1, 2011

Details

Last known activity: Feb 28, 2023